Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- International Institute of Molecular and Cell Biology in Warsaw
- RMIT University
- ;
- ; University of Southampton
- Biobizkaia Health Research Institute
- University of Oslo
- Uppsala University
- ; University of Hertfordshire
- ; University of Warwick
- Academic Europe
- Heidelberg University
- Ilya Pharma
- Institute of Physical Chemistry, Polish Academy of Sciences
- Leibniz
- Leiden University Medical Center (LUMC)
- Linköping University
- Radboud University Medical Center (Radboudumc)
- Stockholm University
- Technical University of Munich
- University of Basel
- University of Louisville
- University of Pittsburgh
- 12 more »
- « less
-
Field
-
Project Title: Investigating mechanisms of intercellular interaction in the lung cancer tumour microenvironment. Faculty of Medicine Main Supervisor: Dr Chris Hanley Other members
-
compounds, cancer or immunotherapy research. The candidate should be familiar with air-sensitive chemistry and general analytical techniques such as FTIR, NMR, electrochemistry, etc. Desirable criteria
-
features of disease stage, progression and therapeutic response. Objective 1: Profile cancer-associated fibroblast heterogeneity in patients with NASH-HCC. Bioinformatics analysis of pre-existing scRNA-seq
-
to aid the design of improved immunotherapies for patients with blood cancer. Patients with chronic lymphocytic leukaemia (CLL) or non-Hodgkin lymphoma who become resistant to current therapies have a poor
-
biomarkers, recurrence prediction, immunotherapy treatment response prediction and other various applications. In this research, you are expected to develop novel methods for cancer data modelling and analysis
-
immunotherapies to fight diseases such as cancer. We are currently advertising a PhD position in this area (funded by an EPSRC DTP Studentship) in the Dept. of Chemistry at Warwick co-supervised by Dr Ann Dixon and
-
Immunotherapy, Cancer Therapeutics, Cancer Virology, and Genome Stability. Successful candidate will have a PhD or equivalent in Biostatistics, Statistics, or related field with ability to work collaboratively
-
oxide nanoparticles that are targeting innate immune cells or T-cells. Animal models of glioma will be employed to study cancer immunotherapies and its mode of action (e.g. targeted therapies, adoptive
-
Signals in Cancer” (Head: Prof. Dr. med. Jürgen Ruland) is to (i) explore the molecular mechanisms and pathways that drive immune dysfunction and immunotherapy resistance, (ii) modulate cancer
-
expression of key molecules that may be important to ovarian cancer immunotherapy and have wider implications for the treatment of chronic disease. Hypothesis: Xanthatin and/or carnosine modulate anti-cancer